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SUMMARY 
Yeast cells lacking Ctf18, the major subunit of an alternative Replication Factor C complex, 
have multiple problems with genome stability.  To understand the in vivo function of the 
Ctf18 complex, we analyzed chromatin composition in a ctf18! mutant using the quantitative 
proteomic technique of SILAC (Stable Isotope Labeling by Amino acids in Cell culture).  
307 of the 491 reported chromosomal proteins were quantitated.  The most marked 
abnormalities occurred when cells were challenged with the replication inhibitor 
hydroxyurea.  Compared to wild-type, hydroxyurea-treated ctf18! cells exhibited increased 
chromatin association of replisome progression complex components including Cdc45, Ctf4 
and GINS complex subunits, the polymerase processivity clamp PCNA and the single-
stranded DNA-binding complex RPA.  Chromatin composition abnormalities observed in 
ctf18! cells were very similar to those of an mrc1! mutant, which is defective in the 
activating the Rad53 checkpoint kinase in response to DNA replication stress.  We found that 
ctf18! cells are also defective in Rad53 activation, revealing that the Ctf18 complex is 
required for engagement of the DNA replication checkpoint.  Inappropriate initiation of 
replication at late origins, due to loss of the checkpoint, probably causes the elevated level of 
chromatin-bound replisome proteins in the ctf18! mutant.  The role of Ctf18 in checkpoint 
activation is not shared by all Replication Factor C-like complexes, since proteomic analysis 
revealed that cells lacking Elg1 (the major subunit of a different Replication Factor C-like 
complex) display a different spectrum of chromatin abnormalities.  Identification of Ctf18 as 
a checkpoint protein highlights the usefulness of chromatin proteomic analysis for 
understanding the in vivo function of proteins that mediate chromatin transactions.  
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INTRODUCTION 
Cells deploy multiple interconnected pathways to ensure accurate chromosome maintenance, 
especially during DNA replication when the unwound DNA helix is vulnerable to DNA 
damage.  An essential component of the replication machinery is Replication Factor C (RFC), 
a 'clamp-loading' complex that loads the polymerase processivity clamp PCNA (proliferating 
cell nuclear antigen) at replication forks (1, 2).  PCNA is central to the replication machinery 
and is a multifunctional complex, acting as a platform that interacts with many proteins 
including DNA polymerases, DNA helicases, nucleases, DNA ligases, histone chaperones, 
DNA repair proteins and sister chromatid cohesion factors (3). RFC is a pentamer consisting 
of a large subunit Rfc1 associated with four smaller proteins Rfc2 through Rfc5 (Rfc2-5).   
 
Interestingly, all eukaryotic cells have a series of RFC-like complexes.  These 'RLC' 
complexes share the Rfc2-5 subunits with RFC, but Rfc1 is replaced by one of a series of 
'alternative' subunits: Rad24 (called Rad17 in human), Elg1, or Ctf18 (4). Rad24-RLC is the 
best understood, and acts to load the PCNA-like complex Rad17-Mec3-Ddc1 (the equivalent 
of the human 9-1-1 complex) at DNA damage sites.  Elg1-RLC and Ctf18-RLC are more 
mysterious.  Elg1-RLC binds PCNA, but has not been reported to load or unload it on DNA.  
elg1! yeast cells exhibit elevated rates of chromosome rearrangement, and are defective in 
sister chromatid cohesion (5-8).  Ctf18-RLC is unique in the RLC family in forming a 
heptamer which contains two additional subunits, called Dcc1 and Ctf8.  In vitro, the Ctf18-
RLC can load PCNA onto DNA and also unload it from DNA (9-11).  Yeast cells lacking 
Ctf18 have multiple problems with genome stability: a ctf18! mutant is viable but shows 
defective sister chromatid cohesion (12), fails to position telomeres at nuclear periphery or 
maintain telomere length (13, 14), and is hypersensitive to the DNA damaging agent MMS 
 4 
and the replication inhibitor hydroxyurea (HU) (15).  Ctf18-RLC appears to act at DNA 
replication forks (16, 17), however, the in vivo function of Ctf18-RLC is unknown. 
 
Since its pleiotropic effects suggest that various chromosome maintenance pathways could be 
affected in the ctf18! mutant, we took a proteomic strategy to investigate chromatin 
abnormalities.  Possible targets of regulation by Ctf18-RLC include proteins involved in the 
processes of DNA replication, the replication stress response, or establishment of sister 
chromatid cohesion.  Central to all these processes is the replisome, the multi-protein 
complex that replicates the DNA, as described below.  Replisome assembly begins during G1 
phase, with the formation of pre-replication complexes by loading of heterohexameric 
Mcm2-7 complexes at origin sites (18).  Replication initiation then involves recruitment by 
Mcm2-7 hexamers of Cdc45 and the GINS complex (containing the four subunits Sld5, 
Psf1, Psf2, and Psf3), leading to assembly of the Cdc45-MCM-GINS complex.  Cdc45-
MCM-GINS is central to replisome function, probably forming the activated replicative 
helicase that unwinds the DNA, enabling its replication on the leading strand by DNA 
polymerase ! and on the lagging strand by DNA polymerase " (along with its processivity 
factor PCNA and the DNA polymerase # priming complex) (18-20).  During the replication 
process, exposed single-stranded DNA is coated by the single-stranded binding protein RPA 
(containing subunits Rfa1, Rfa2 and Rfa3) to stabilize and protect it. 
 
A recent biochemical study revealed that the Cdc45-MCM-GINS is the central component of 
the so-called 'replisome progression complex' (RPC), which contains additional factors 
including Ctf4 (21).  Ctf4 appears to link Cdc45-MCM-GINS to Polymerase # (22, 23), and 
is required for the establishment of cohesion (12), the mechanism through which duplicated 
sister chromatids are held together until anaphase.  Sister chromatids are held together by the 
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ring-shaped cohesin complex, which contains subunits Smc1, Smc3, Scc1 and Scc3. (24).  
Establishment of cohesion appears to be closely coupled to replication through RPC-
mediated events, and yeast cells lacking RPC proteins such as Ctf4 display cohesion defects 
(25). 
 
A further component of the RPC is the checkpoint mediator protein Mrc1, essential for cells 
to respond correctly to replication stress, such as fork blockage events induced by the DNA 
replication inhibitor HU (21, 26, 27).  In response to replication stress, eukaryotic cells 
activate a DNA replication checkpoint pathway that suppresses new replication initiation 
events at unfired origins, stabilizes replication forks, induces transcription of DNA stress 
response genes, and delays cell cycle progression (28).  The current model suggests that a 
checkpoint kinase Mec1, the budding yeast homolog of human ATR, is recruited to 
replication block sites and phosphorylates target proteins.  One of the targets is Mrc1, which 
provides an activation platform for the checkpoint kinase Rad53 to initiate the checkpoint 
response (27).  mrc1! cells demonstrate a significant delay in Rad53 activation in response to 
a replication block (26).  In wild-type cells HU treatment causes suppression of further 
replication initiation events, but HU-treated mrc1! cells inappropriately initiate replication at 
late origins, due to failure of DNA replication checkpoint activation (26, 29).  
 
To investigate the in vivo function of Ctf18-RLC, we analyzed the differences in chromatin 
composition between wild-type and ctf18! cells.  We took advantage of recent advances in 
quantitative protein mass spectrometry, which provide the tools to enable the analysis of 
entire chromatin composition in an unbiased way.  Here, we have applied Stable Isotope 
Labeling by Amino acids in Cell culture (SILAC)-based quantitative proteomics (30) for 
comparison of chromatin components from wild-type and ctf18! Saccharomyces cerevisiae.  
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Budding yeast provides an ideal organism for developing this work due to its small, relatively 
well-characterized proteome.  This novel approach has provided us with a large-scale view of 
changes in chromatin composition in a ctf18! mutant, and revealed that the Ctf18-RLC 
complex acts in the same pathway as Mrc1 to mediate the DNA replication checkpoint. 
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EXPERIMENTAL PROCEDURES 
 
Yeast strains 
S. cerevisiae strains used are listed in Supplemental Table S1.  SHY201 was generated by 
sporulation of the diploid strain BY4743 and selection of a MATa lysine auxotroph, followed 
by disruption of ARG4.  To construct TKY1, a ctf18!::kanMX4 construct was PCR-amplified 
from the relevant EUROSCARF gene deletion strain and transformed into SHY201.  TKY18, 
TYK130, and TKY131 were constructed in the same way, using elg1!::kanMX4 and 
rad9!::kanMX4 fragments.  A strain carrying a deletion of the entire MRC1 gene was created 
by PCR-based one-step gene replacement using pFA6a-kanMX6 as a template (31).  Myc-, 
FLAG- and HA-tagging was carried out using standard PCR-based gene insertion methods 
(31).  Disrupted and tagged alleles were confirmed by PCR.  Primer sequences are available 
on request. 
 
SILAC labeling 
For lysine and arginine double labeling, lys2! arg4! strains TKY1, TKY18 or TKY111 were 
grown for at least ten generations in 'heavy' medium, which is synthetic yeast medium 
containing: 6.9 g/l yeast nitrogen base without amino acids (FORMEDIUM), 1.85 g/l amino 
acid dropout mixture without arginine and lysine (Kaiser formulation, FORMEDIUM), 2% 
glucose, 15 mg/l [
13
C6]L-arginine and 30 mg/l [
13
C6] or [
13
C6,
15
N2]L-lysine.  SHY201 cells 
were grown in 'light' medium, containing 15 mg/l L-arginine and 30 mg/l L-lysine.  For 
lysine single labeling, TKY1 or SHY201 cells were grown for ten generations in the same 
synthetic medium but containing 15 mg/l L-arginine and either 30 mg/l [
13
C6]L-lysine or 30 
mg/l L-lysine. 
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Cell synchronization and release 
Cells were grown in heavy or light media at 30°C to early log phase (~3 $ 10
6
 cells/ml), and 
synchronized by treating with 5 µg/ml #-factor for 2.5 hr at 30°C.  For release into HU, cells 
were spun down, washed once in heavy or light medium, re-suspended in HU-containing 
heavy or light medium, and incubated with shaking for 1.5 hr at 30°C.  To release cells from 
#-factor arrest into normal S phase, cells were synchronized in the same way and 
resuspended in heavy or light media lacking HU.  The cultures were then incubated with 
shaking at 30°C and harvested at a mid-S phase time point, as determined by flow cytometry 
analysis.  Flow cytometry was carried out using SYTOX Green nucleic acid stain (Invitrogen 
Molecular Probes) as previously described (32). 
 
Preparation of chromatin-enriched fraction 
Chromatin enriched-fractions were prepared according to Sheu et al. (33), modified to 
incorporate a nuclear isolation procedure (34).  Approximately 4 $ 10
9
 cells (~1 $ 10
7
 
cells/ml) were harvested and resuspended in 10 ml of prespheroplasting buffer (100 mM 
PIPES/KOH, pH 9.4, 10 mM DTT, 0.1% sodium azide) then incubated for 10 min at room 
temperature, followed by incubation in 10 ml of spheroplasting buffer (50 mM 
KH2PO4/K2HPO4, pH 7.4, 0.6 M Sorbitol, 10 mM DTT) containing 200 µg/ml Zymolyase-
100T and 5% Glusulase at 37°C for 30 min with occasional mixing.  Spheroplasts were 
washed with 5 ml of ice-cold wash buffer (20 mM KH2PO4/K2HPO4, pH 6.5, 0.6 M Sorbitol, 
1 mM MgCl2, 1 mM DTT, 20 mM %-glycerophosphate, 1 mM PMSF, Protease inhibitor 
tablets (EDTA free, Roche)) and resuspended in 5 ml of ice-cold wash buffer.  The 
suspension was overlaid onto 5 ml of 7.5% Ficoll-Sorbitol cushion buffer (7.5% Ficoll, 20 
mM KH2PO4/K2HPO4, pH 6.5, 0.6 M Sorbitol, 1 mM MgCl2, 1 mM DTT, 20 mM %-
glycerophosphate, 1 mM PMSF, Protease inhibitor tablets) and the spheroplasts were spun 
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through the cushion buffer at 5,000 rpm for 5 min to remove proteases derived from 
Zymolyase-100T.  The pelleted spheroplasts were resuspended in 200 µl of ice-cold wash 
buffer and dropped into 14 ml of 18% Ficoll buffer (18% Ficoll, 20 mM KH2PO4/K2HPO4, 
pH 6.5, 1 mM MgCl2, 1 mM DTT, 20 mM %-glycerophosphate, 1 mM PMSF, Protease 
inhibitor tablets, 0.01% NP40) with stirring.  At this stage, it was confirmed microscopically 
that the cytoplasmic membranes were lysed, but that nuclei and vacuoles (often attached 
together) were intact.  The suspension was subjected to 10 strokes with a loose-fitting pestle 
in a Potter-Elvehjem homogenizer (which releases nuclei from vacuoles and improves 
recovery of nuclei).  Unbroken cells were removed by two low-speed spins (5,000 $ g for 5 
min at 4°C).  Nuclei were then pelleted by a high-speed spin (16,100 $ g for 20 min) and the 
cytoplasmic fraction removed.  After washing nuclei in ice-cold wash buffer, the nuclei were 
resuspended in 200 µl of EB buffer (50 mM HEPES/KOH, pH 7.5, 100 mM KCl, 2.5 mM 
MgCl2, 0.1 mM ZnSO4, 2 mM NaF, 0.5 mM spermidine, 1 mM DTT, 20 mM %-
glycerophosphate, 1 mM PMSF, Protease inhibitor tablets) and lysed by addition of Triton X-
100 to 0.25%, followed by incubation on ice for 10 min.  The lysate was overlaid on 500 µl 
of EBX-S buffer (EB buffer, 30% sucrose, 0.25% Triton X-100), and spun at 12,000 rpm for 
10 min at 4°C.  The top layer (nucleoplasmic fraction) was removed and the chromatin pellet 
was washed in 1 ml of EBX buffer (EB buffer, 0.25% Triton X-100) and spun at 10,000 rpm 
for 2 min at 4°C.  The chromatin pellet was resuspended in 40 µl of 1.5$ Tris-Glycine SDS 
Sample Buffer and incubated for 2 min at 85°C, followed by spinning at 10,000 rpm for 30 
sec before loading on a Novex 8-16% Tris-Glycine Gel (Invitrogen).  Whole cell extract was 
prepared by lysing the washed spheroplasts in EBX buffer.  Protein concentration of whole 
cell extract was measured using Qubit Fluorometer and Quant-iT Protein Assay Kit 
(Invitrogen).  Protein concentration of chromatin fraction was calculated by comparing 
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intensities of protein bands of chromatin fraction with those of whole cell extract on SYPRO 
Ruby (Bio-Rad) stained gel.  
 S phase chromatin was prepared in the same way (see above) with the following 
adjustments: sodium azide was added directly to the culture to a final concentration of 0.1%, 
and the culture was immediately chilled on ice for 10 min.  After harvesting, the cells were 
resuspended and incubated in prespheroplasting buffer for 10 min on ice (instead of at room 
temperature).  0.1% sodium azide was included in the spheroplasting buffer.  
 Wild-type and ctf18! chromatin were prepared separately and then mixed, to avoid 
complications arising from differences of these strains in cell size and susceptibility to 
spheroplasting enzymes. 
 
Mass spectrometry and data analysis 
Equal amounts (60 µg each) of proteins from chromatin-enriched fractions (differentially-
labeled with isotopes) were mixed and size-fractionated by 1D SDS-PAGE (Novex 8-16% 
Tris-Glycine Gel, Invitrogen).  Proteins were visualized by colloidal Coomassie staining 
(Colloidal Blue Staining Kit, Invitrogen), and the entire protein gel lane was excised and cut 
into 12 slices.  The gel slices were destained in dH2O and 20 mM NH4HCO3.  Each gel slice 
was subjected to in-gel digestion with trypsin (Trypsin Gold, Promega) (for lysine- and 
arginine-labeled proteins) or Lys-C (Lysyl Endopeptidase, Wako) (for lysine-labeled 
proteins) (35).  The resulting peptides were extracted and analyzed in automated LC-MS/MS 
as described previously (36).  Mass spectrometry analysis was performed using a nanoflow 
HPLC system connected to a linear ion trap-orbitrap hybrid mass spectrometer (LTQ-
Orbitrap XL or Velos, Thermo Fisher Scientific Inc) via a nanoelectrospray ion source 
(Proxeon Biosystems) (36). 
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  Quantitation was performed using the program MaxQuant (version 1.0.12.31. or 
1.0.13.13) (37). The derived peak list generated by Quant.exe (in the first part of MaxQuant) 
was searched using the Mascot search engine (Matrix Sciences, version 2.2.2) for peptide 
identifications against the yeast GenBank database (released May 2006), containing 11,168 S. 
cerevisiae protein sequences with the addition of 175 commonly observed contaminants and 
all the reversed sequences. The initial mass tolerance was set to 7 ppm, and MS/MS mass 
tolerance was 0.5 Da. The enzyme was specified as trypsin or Lys-C, with a maximum of two 
missed cleavages. Carbamidomethylation of cysteine was searched as a fixed modification, 
whereas N-acetyl protein and oxidation of methionine were searched as variable 
modifications.  As discussed in Cox et al. (37), peptides and proteins were accepted in 
reverse order of their PEP (probability of false hit) scores while the number of forward 
database identifications remained 100-fold higher than the number of reverse database 
identifications (i.e. until reverse identifications exceeded 1% of those accepted), thus 
resulting in a false discovery rate of 1%.  Because the use of MaxQuant software has 
significantly improved reliability and accuracy of peptide quantitation and assignment to 
proteins (37), proteins were considered to be identified if represented by at least one unique 
peptide, and were considered quantified if they had at least one quantified SILAC pair.  The 
data quality (in particular, the number of unique peptides and number of quantification events 
for each protein) was however an important additional parameter when considering the 
confidence to be given to specific results.  Taking account of the data quality, we indicate the 
names of a selected number of proteins that were quantitated by at least two peptides in 
Figures 3A, 4B, 6D, 7A and 7C. 
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Categorization of proteins 
Protein categorization annotations are generally according to the Gene Ontology Cellular 
Component (GOCC) in the Saccharomyces Genome Database.  Where GOCC makes 
multiple assignments for a particular gene product, it was assigned to the category appearing 
first in the following list: Chromosome, Nucleolus, Nucleoplasm, Cytoplasm, Other.  For 
example, a protein with a GOCC annotation 'chromosomal, nuclear and cytoplasmic' was 
assigned to the category 'chromosome' (and not to 'nucleoplasm' or 'cytoplasm').  Potential 
proteins encoded by dubious ORFs were included in the category 'Other'.  Some probable 
chromatin proteins (e.g. transcription, chromatin remodelling and repair proteins, such as 
RNA polymerase components, SWI/SNF, SAGA, and RSC subunits, 'Rad' proteins, Mec1 
and Tel1) were manually re-allocated from 'nucleoplasm' to 'chromosome' categories. 
 
Quantification of proteins in chromatin-enriched fractions by Western blotting  
Whole cell extracts and chromatin-enriched fractions were prepared from HU-arrested 
cultures of epitope-tagged strains as described above.  Samples were electrophoresed on 
NuPAGE 4-12% Bis-Tris gels (Invitrogen) gels and blotted on PVDF membrane (Hybond-P, 
GE Healthcare).  Antibodies used in detection of epitope-tagged proteins were mouse anti-
HA (HA.11, Covance) and mouse anti-Myc (ab32, Abcam).  Antibodies used in detection of 
Mcm2, Adh1 and histone H3 were goat anti-Mcm2 (sc-6680, Santa Cruz), rabbit anti-Adh1 
(ab34680, Abcam), and rabbit anti-histone H3 (ab46765, Abcam).  Secondary antibodies 
were alkaline phosphatase (AP)-conjugated anti-mouse IgG (sc-2008, Santa Cruz), AP-
conjugated anti-rabbit IgG (S3731, Promega), and AP-conjugated anti-goat IgG (sc-2022, 
Santa Cruz).  The detection substrate was ECF Western blotting reagent (GE Healthcare).  
Chemifluorescent signals were scanned by FLA-3000 (excitation, 473 nm; filter, O580, 
FUJIFILM) and quantified using ImageGauge V4.21 software.  To compare the amounts of 
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proteins in chromatin fractions from WT and mutant (Fig. 3, 4 and 7), a standard plot was 
drawn based on analysis of a dilution series of chromatin from WT (e.g. Supplemental Fig. 
S3), and values for experimental samples were measured by placement on that plot.  Values 
were adjusted for variations in loading based on histone H3 signal.  To compare chromatin-
bound PCNA in WT and elg1! cells by Western blot, chromatin fractions were prepared as 
described above and PCNA was detected using mouse monoclonal anti-PCNA antibody 
(ab70472, Abcam). 
 
Immunoprecipitation 
Approximately 2 $ 10
8
 spheroplasts were resuspended in 600 µl of lysis buffer (50 mM 
HEPES/KOH, pH 7.5, 150 mM NaCl, 3 mM MgCl2, 10% glycerol, 0.2% NP-40, 10 mM 
NaF, 20 mM %-glycerophosphate) containing protease inhibitors (1$ Complete (Roche), 1% 
Protease Inhibitor Cocktail (Sigma P8215)).  Lysates were treated with 200 units of DNase I 
(Roche) at 4°C for 30 min and then centrifuged to produce cleared whole cell extract.  This 
extract was incubated with 2 µg of anti-FLAG M2 antibody (Sigma) conjugated with 20 µl of 
Dynabeads Protein G (Dynal) at 4°C for 2 h.  Samples were washed four times with lysis 
buffer, and then resuspended in SDS sample buffer.  To examine Mcm4 binding for Cdc45 
and Pol1, EBX buffer (as used for chromatin fractionation) or low salt buffer (50 mM 
HEPES/KOH, pH 7.5, 50 mM potassium acetate, 10 mM magnesium acetate, 1 mM DTT, 
10% glycerol, 0.1% NP-40, 2 mM NaF, 2 mM %-glycerophosphate, 1$ Complete (Roche), 
1% Protease Inhibitor Cocktail (Sigma P8215)) was used instead of lysis buffer. Cdc45 
protein was detected using sheep polyclonal anti-Cdc45 antibody (kindly gifted from Dr. 
Karim Labib).   
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Two-dimensional gel  
Genomic DNA was prepared as described (38, 39).  DNA fragments digested using EcoRI 
were separated by neutral/neutral two-dimensional agarose gel electrophoresis (40) and 
transferred to Neutral membrane (Qbiogene) by capillary blotting. EcoRI fragments 
containing ARS305 and ARS1413 were detected using suitable 
32
P-labeled probes. 
 
Rad53 phosphorylation 
SHY201, TKY1, TKY18, TKY111, TKY130, or TKY131 cells were arrested in G1 phase 
using #-factor, and released into S phase in the presence or absence of 200 mM HU at 25°C.  
Cells were sampled at indicated time points, washed twice with water and incubated in 0.1M 
NaOH for 5 min at room temperature.  The cells were spun down and resuspended in SDS 
sample buffer before SDS-PAGE electrophoresis and Western blotting as described above.  
Rad53 protein was detected using a goat polyclonal anti-Rad53 antibody (sc-6749, Santa 
Cruz Biotechnology). 
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RESULTS 
Workflow for quantitative analysis of chromatin components in wild-type and ctf18! cells!
To understand the in vivo function of Ctf18-RLC, we used SILAC-based comparative 
proteomics (30) to compare chromatin composition in wild-type and ctf18! cells (Fig. 1A).  
ctf18! cells were grown in 'heavy' media, i.e., containing 
13
C/
15
N-substituted arginine and/or 
lysine; complete labeling of cellular proteins was facilitated by the use of lysine and arginine 
auxotrophic mutants (lys2! arg4!).  Wild-type cells were grown in 'light', i.e., unlabeled 
(
12
C/
14
N) media.  Both wild-type and ctf18! cultures were synchronized during DNA 
replication by release from G1 phase arrest into medium containing the replication inhibitor 
HU.  Chromatin proteins were prepared from wild-type and ctf18! cells separately (see Fig. 
2A), mixed and then size-fractionated using SDS-PAGE, followed by trypsin or Lys-C 
digestion (as appropriate for the labeling regime used in each experiment).  The resulting 
peptides were analyzed by high sensitivity mass spectrometry LTQ-Orbitrap.  
 
Peptides originating from ctf18! cells mirror those from wild-type cells, but show a shift in 
mass due to their content of heavy arginine and/or lysine.  For proteins whose loading on 
chromatin is altered in ctf18!, the change is reflected in the abundance of heavy-labeled 
peptides.  A specimen MS spectrum for a PCNA peptide is shown in Fig. 1B.  This heavy and 
light peptide pair (SILAC peptide pair) indicates an approximately two-fold increase in 
PCNA in the ctf18! chromatin preparation, compared to wild-type.  Using MaxQuant 
software (37), protein ratios are calculated as the median of all SILAC peptide pair ratios for 
each protein identified, including a normalization step adjusting for any inequality in protein 
loading in the two samples. 
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Validation of chromatin preparation 
When we used a published chromatin enrichment protocol (33), we found that only 44% of 
proteins quantitated were nuclear or chromosomal and the remainder were cytoplasmic or 
other contaminants of the chromatin preparation (data not shown).  To refine the analysis, we 
incorporated a nuclear isolation procedure (adapted from Young et al. (34)) into the protocol 
(Fig. 2A and Supplemental Fig. S1).  A chromatin-enriched fraction prepared by this 
modified procedure was analyzed by SDS-PAGE and SYPRO Ruby staining (Fig. 2B).  
Western blotting demonstrated that chromatin proteins (the MCM complex subunit Mcm2 
and histone H3) were efficiently recovered, whereas the cytoplasmic protein Adh1 was 
undetectable in the chromatin-enriched fraction (Fig. 2C).  With this modified procedure, 
56% of proteins identified by mass spectrometry were nuclear or chromosomal, covering 
63% (307 out of 491) of chromosomal proteins (Fig. 2D).  As a category, chromosomal and 
nucleolar proteins were recovered and identified in the highest proportions.  Many 
contaminating cytoplasmic proteins were nevertheless quantitated, as expected since our 
chromatin enrichment procedure does not constitute a full chromatin purification.  Because 
our purpose was to measure, rather than to identify, chromatin proteins, the contaminating 
cytoplasmic proteins do not interfere with quantification of chromatin components.  Thus, we 
had established a suitable methodology for analyzing chromatin composition using SILAC 
quantitative proteomics. 
 
Chromatin binding of DNA replication proteins (PCNA, RPA, GINS and Ctf4), the 
checkpoint kinase Mec1, and cohesin are increased in HU-treated ctf18! cells 
To emphasize consistent changes within related groups of proteins, we plot graphs showing 
both heavy/light ratios and relative peptide abundance (i.e. MS peptide intensity) (37, 41).  
Log2 ratios of the 307 identified chromosomal proteins are plotted against summed MS 
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peptide intensities for each protein (Fig. 3A).  Validating the approach, 'heavy' peptides 
derived from Ctf18 protein were not identified, and the protein showing the largest decrease 
on chromatin in the ctf18! mutant was the Dcc1 subunit of Ctf18-RLC (Fig. 3A).  The Ctf8 
subunit of Ctf18-RLC was not identified in this experiment.  The list of chromosomal 
proteins quantitated is shown in Supplemental Table S2.  One striking abnormality observed 
in HU-treated ctf18! cells was a two- to four-fold increase in many replisome factors--
including PCNA, single-strand DNA-binding proteins Rfa1, Rfa2, and Rfa3, GINS complex 
proteins Psf1, Psf2, and Psf3, the Ctf4 connector protein that binds GINS and Pol #, and the 
checkpoint kinase Mec1.  We also observed a modest, but reproducible, increase in 
chromatin loading of the cohesin complex components Smc1, Smc3, and Scc3, and the 
cohesion establishment factor Pds5 (Fig. 3A).  We observed a slight decrease in the telomeric 
chromatin component Rap1, and Pol #-primase subunits Pol12 and Pri2 (Fig. 3A).  Since 
Rap1 binds telomere repeat sequences, a reduction in chromatin-bound Rap1 is consistent 
with the shortened telomeres observed in ctf18! cells (14).  Figure 3B shows a color-coded 
schematic representation of the changes we observed.  We repeated this experiment with 
minor modifications and observed similar chromatin abnormalities (Supplemental Fig. S2 
and Table S3).   
  
To confirm the changes observed, we epitope-tagged specimen proteins and performed 
Western blotting to examine their representation in chromatin preparations from HU-treated 
wild-type and ctf18! cells.  Overall expression levels of Rfa1-3HA, Ctf4-13Myc, PCNA-
3Myc, and Psf2-13Myc were similar in wild-type and ctf18!, as assessed by analysis of 
whole cell extracts (Fig. 3C).  However, these proteins were increased, when compared to 
wild-type, in chromatin-enriched fractions prepared from HU-treated ctf18! (Fig. 3C, D & 
Supplemental Fig. S3).  The levels of increase closely reflect the changes observed by SILAC 
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mass spectrometry (Fig. 3E).  In summary, we successfully used SILAC quantitative 
proteomics to detect abnormalities in ctf18! chromatin, observing the most significant 
change to be increased loading of various replisome components.   
 
Chromatin loading of replisome components did not increase in the ctf18! mutant in normal 
S phase 
ctf18! cells show cohesion and telomere defects in normal growth (12, 13), so we tested for 
chromatin abnormalities in ctf18! cells in an unchallenged S phase ('normal' S phase).  We 
used SILAC to compare chromatin isolated from wild-type and ctf18! cultures progressing 
synchronously through normal DNA replication.  For these experiments, unlabeled wild-type 
and labeled ctf18! cultures were released from G1 arrest and sampled at a mid-S phase time 
point (Fig. 4A).  Chromatin was then prepared for SILAC-based chromatin profiling as 
described above.  In general, we observed only slight abnormalities in ctf18! chromatin 
composition, and the changes observed on HU treatment were not apparent in normal S phase 
(Fig. 4B and Supplemental Table S4).  The levels of cohesin loading appeared very similar to 
wild-type (Supplemental Fig. S4).  Chromatin loading of DNA replication proteins (such as 
RPA components Rfa2 and Rfa3, GINS, and Ctf4) was in general not substantially changed 
in ctf18! when compared to wild-type.  We did observe a slight increase in loading of Rfa1, 
and a slight decrease in chromatin loading of the DNA polymerase " catalytic subunit Pol3 
(Fig. 4B).  Loading on chromatin of PCNA was also slightly decreased in ctf18! during 
normal S phase (Fig. 4B, C and D), in contrast to its behavior in HU-treated ctf18! cells 
where PCNA loading was increased.  We repeated this experiment and observed similar 
changes (Supplemental Fig. S5 and Table S5).  Taken results in Figures 3 and 4 together, we 
conclude that the increased loading of replisome components onto chromatin in ctf18! cells 
occurs in response to HU, and is not observed in ctf18! cells undergoing normal S phase.  
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Excess active helicase complex is present in HU-treated ctf18! cells 
GINS and Ctf4 are subunits recruited to the MCM helicase during RPC formation (21).  The 
increased GINS and Ctf4 observed in the chromatin fraction of HU-treated ctf18! cells (Fig. 
3) suggested an increase in the proportion of GINS and Ctf4 complexed with MCM 
(suggesting a larger number of RPCs).  To test this possibility, we immunoprecipitated 
Mcm4-3FLAG and compared the amount of Ctf4-13Myc or the GINS subunit Psf2-13Myc 
that co-immunoprecipitated in wild-type and ctf18! cells (Fig. 5A and B).  We found that the 
amounts of Ctf4 and Psf2 complexed with Mcm4 were noticeably increased in HU-treated 
ctf18! cells (Fig. 5A, B and D).   
 
Next, we examined whether Cdc45 showed increased association with Mcm4.  Cdc45 forms 
another central subunit of the RPC, and showed slightly increased chromatin association in 
HU-treated ctf18! cells in SILAC experiments (Fig. 3B and Supplemental Fig. S4).  Using 
co-IP analysis, we observed a substantial increase in Cdc45-Mcm4 complex formation in 
HU-treated ctf18! cells (Fig. 5C and D), of similar magnitude to that observed for Psf2 and 
Ctf4.  These co-immunoprecipitation experiments show increased binding to Mcm4 of 
Cdc45, GINS subunit Psf2, and Ctf4 and together suggest that excess active replicative 
helicase is present in HU-treated ctf18! cells.   
 
Ctf4 binds to GINS and DNA Pol # and is thought to form a physical connector between the 
replicative helicase complex Cdc45-MCM-GINS and the DNA Pol #-primase complex (22, 
23).  Although Ctf4 association with chromatin increased in HU-treated ctf18! cells, the 
SILAC analysis suggested that chromatin association of Pol #-primase subunits, such as 
Pol1, Pol12 and Pri2, actually decreased (Fig. 3A and Supplemental Fig. S4), potentially 
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suggesting an imbalance in replisome components.  We used co-IP to examine whether the 
amount of Pol1 binding to the helicase complex in HU-treated ctf18! cells is really reduced.  
Consistent with the SILAC data, slightly less Pol1 appeared to associate with Mcm4 in HU-
treated ctf18! when pull-down was carried out under the same buffer conditions as for 
SILAC chromatin fractionation (Fig. 5C upper three panels).  However, the signal from co-
immunoprecipitated Pol1 was weak and close to background level.  To improve Pol1 signal 
strength, we performed immunoprecipitation under lowered salt conditions (50 mM 
potassium acetate) as described previously (22).  With this adjustment, Pol1 signal strength 
was increased and it was clear that in HU-treated ctf18! cells, the amount of Pol1 associated 
with Mcm4 is elevated (Fig. 5C bottom and D).  This observation suggests that in HU-treated 
ctf18! cells the amount of active, replisome-associated Pol1 (and Pol #-primase) is in fact 
increased, like other RPC components.  It appears however that particular characteristics of 
the Pol #-primase complex preclude identification of this increase by SILAC (see 
Discussion).  
 
Ctf18 is required for full activation of Rad53 in response to HU 
The hundreds of replication origins in the S. cerevisiae genome initiate replication 
sequentially according to a temporal program (42).  In wild-type cells exposed to HU, 
initiation at late origins is inhibited by the DNA replication checkpoint pathway.  In mutant 
cells deficient in the DNA replication checkpoint (e.g. mrc1!), late origins are activated (26, 
29).  One possibility is that the excess active helicase complex present in HU-treated ctf18! 
cells is caused by inappropriate initiation and RPC formation at late replication origins, due 
to a defective DNA replication checkpoint.  To test this idea, we examined whether late 
origin ARS1413 fires in HU-treated ctf18! cells using two-dimensional gel analysis.  No 
replication intermediates were detected at ARS1413 in HU-treated wild-type cells, but a clear 
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bubble arc was detected in HU-treated ctf18! (Fig. 6A), indicative of initiation at ARS1413 
and suggestive of a defect in the replication checkpoint.   An even more intense bubble arc at 
ARS1413 in mrc1! cells may reflect differing kinetics in ctf18! and mrc1! strains of 
activating the DNA damage checkpoint, which also affects late origins (see below). 
 
HU exposure causes hyperphosphorylation of the checkpoint kinase Rad53 and stimulation of 
its kinase activity (43).  We compared the phosphorylation kinetics of Rad53 in HU-treated 
wild-type and ctf18! cells (Fig. 6B). We found that Rad53 phosphorylation was delayed in 
HU-treated ctf18! cells, similar to the delay in mrc1! cells (compare 30 min time points).  
We conclude that Ctf18 is required for timely activation of Rad53 and efficient DNA 
replication checkpoint engagement in response to HU.  In the absence of the Mrc1-mediated 
replication checkpoint, HU treatment causes accumulating DNA damage, with the result that 
Rad53 becomes phosphorylated through the Rad9-dependent DNA damage checkpoint 
pathway (26).  To test whether the somewhat delayed Rad53 activation in HU-treated ctf18! 
cells depends on the Rad9 pathway, we constructed a ctf18! rad9! double mutant and tested 
phosphorylation kinetics of Rad53.  On HU treatment, phosphorylated forms of Rad53 
accumulate in rad9! cells, but are hardly detected in the ctf18! rad9! double mutant in HU 
(Fig. 6C).  These results suggest that Ctf18, like Mrc1, is required to activate the DNA 
replication checkpoint pathway.  In the absence of Ctf18, Rad53 activation occurs only 
through the Rad9-dependent checkpoint pathway, and probably reflects accumulating DNA 
damage.   
 We conclude that the excess active helicase present in HU-treated ctf18! cells results 
from inappropriate initiation at late replication origins due to a defect in the DNA replication 
checkpoint.   
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Alteration of chromatin composition in HU-treated ctf18! cells is similar to that in HU-
treated cells lacking a checkpoint mediator Mrc1 
We used SILAC quantitative proteomics to examine the chromatin of HU-treated mrc1! 
cells, to test whether the chromatin abnormalities observed in ctf18! cells are similar to those 
of another checkpoint-deficient mutant.  We found increased chromatin association of 
replication proteins including PCNA, Cdc45, GINS components, Ctf4, and RPA subunits in 
HU-treated mrc1! cells (Fig. 6D and Supplemental Table S6), very similar to the changes 
observed for the ctf18! mutant exposed to HU.  The similarity in chromatin profile between 
HU-treated ctf18! and mrc1! included a slight increase in chromatin association of the 
cohesin complex (Fig. 6E).  The close resemblance of chromatin profiles of HU-treated 
mrc1! and ctf18! mutants supports the suggestion that Ctf18 acts in the same pathway as 
Mrc1 in the cellular response to HU, affecting chromatin through the DNA replication 
checkpoint. 
 
HU treatment of cells lacking the Elg1-RLC reveals a spectrum of chromatin abnormalities 
that differs from ctf18!  
The function of Elg1-RLC, another alternative RFC complex, is not well understood.  To 
investigate the function of Elg1-RLC, we used SILAC to compare chromatin fractions from 
HU-treated wild-type and elg1! cells.  There was no significant increase in chromatin 
association of Cdc45, GINS, Ctf4, RPA, Mec1 and the cohesin complex subunits Scc1 and 
Scc3 in HU-treated elg1! cells (Fig. 7A and Supplemental Table S7).  This chromatin profile 
differs sharply from the ctf18! mutant and suggests that Elg1 is not essential for activation of 
DNA replication checkpoint.  Interestingly, we observed that chromatin association of PCNA 
and the flap endonuclease Rad27 (a yeast FEN1 homologue) was substantially increased in 
HU-treated elg1! cells (Fig. 7A and B).  Rad27 is believed to act in Okazaki fragment 
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processing and maturation.  Chromatin association of PCNA and Rad27 was also abnormally 
high during normal S phase in elg1! cells (Fig. 7C, D and Supplemental Table S8).  
Increased chromatin loading of PCNA in elg1! is consistent with recently published data 
(44). Finally, we confirmed that the DNA replication checkpoint is intact in elg1! cells, by 
demonstrating that late origin ARS1413 is repressed and Rad53 phosphorylation occurs 
normally in HU-treated elg1! cells (Fig. 7E and F).  Elg1 is therefore not required for the 
DNA replication checkpoint, and that the chromatin composition abnormalities seen in elg1! 
presumably result from a different defect. Despite certain phenotypic similarities (7, 8), 
Ctf18-RLC and Elg1-RLC therefore appear to have distinct in vivo functions in DNA 
metabolism. 
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DISCUSSION 
 
To investigate the role of Ctf18-RLC in S phase, we utilized SILAC-based proteomics to 
analyze chromatin composition.  About 63% of known chromatin proteins were identified 
and quantified (Fig. 2D).  We found significant and reproducible changes in chromatin 
composition in the ctf18! mutant, which were confirmed by Western blot analysis (Fig. 3).  
The results demonstrate that our quantitative proteomic approach is useful to obtain a large-
scale view of changes in chromatin composition.   
 
Ctf18 is required for DNA replication checkpoint activation 
SILAC proteomic analysis revealed increases in chromatin-bound RPC components such as 
GINS, Cdc45 and Ctf4 in HU-treated ctf18! cells, suggesting the presence of excess active 
DNA helicase complex (Fig. 3).  Immunoprecipitation assays confirmed that the amount of 
Mcm4-bound GINS, Cdc45 and Ctf4 (Fig. 5) was increased, suggesting increased RPC 
formation and the presence of a larger number of active replisomes.  Because this effect was 
observed only when replication was challenged by HU and not during normal S phase (Fig. 3 
and 4), we suspected that the apparent increase in active replisomes might reflect 
inappropriate late origin initiation due to defective DNA replication checkpoint activation.  
We found that a late origin is derepressed in HU-treated ctf18! cells (Fig. 6A) and 
phosphorylation of the checkpoint kinase Rad53 is delayed (Fig. 6B), showing that Ctf18 is 
required for normal activation of the replication checkpoint.  The close resemblance of 
chromatin composition profiles from HU-treated ctf18! cells and mrc1! cells (Fig. 6E) 
supports the idea that most of the abnormalities observed in HU-treated ctf18! chromatin are 
caused by defective DNA replication checkpoint activation.  Using a different approach 
Crabbé et al. (45) also recently showed that Ctf18-RLC is required for the DNA replication 
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checkpoint.  Our results are moreover consistent with previous data suggesting that the 
Ctf18-RLC subunits Dcc1 and Ctf8 are required for the DNA replication checkpoint pathway 
(46), and with the suggestion that lack of human Ctf18-RLC alters the dynamics of 
replication. (47).  
The Rad53 phosphorylation that does still occur in the ctf18! mutant on HU treatment 
depends on the Rad9-mediated DNA damage checkpoint.  The delay to Rad53 activation in 
the absence of Ctf18 probably provides a time window allowing initiation at late origins.  The 
fairly slight retardation of Rad53 phosphorylation probably explains why earlier studies of 
the ctf18! mutant (which used less rigorous sampling protocols) did not detect a checkpoint 
defect (5, 48).  
 
Chromatin profile abnormalities of HU-treated ctf18! cells could result from a defective 
DNA replication checkpoint 
ctf18! cells show defects in sister chromatid cohesion (12). Cohesin loading on chromatin 
appeared normal in ctf18! cells in an unchallenged S phase.  Unexpectedly however, we 
observed slightly increased loading of the cohesin complex on chromatin in HU-treated 
ctf18! cells (Fig. 3 and Supplemental Fig. S4).  Extra cohesin is therefore loaded onto 
chromatin when replication is blocked in ctf18! cells, when compared to wild-type.  In 
addition to the normal quota of cohesin loaded in late G1 phase, extra cohesin can be loaded 
onto chromatin during G2/M phase to reinforce cohesion at sites of DNA damage (49).  We 
suspect that the additional cohesin observed on chromatin in HU-challenged ctf18! cells 
reflects a cellular response to abnormal levels of DNA damage, which may result from the 
formation of extended tracts of single-stranded DNA in HU-treated ctf18! cells due to the 
replication checkpoint activation defect.  Regions of single-stranded DNA have been 
observed at HU-blocked replication forks in checkpoint-deficient mutants (50).  Increased 
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chromatin loading of the repair protein Rad52 in HU-treated ctf18! and mrc1! cells 
(Supplemental Fig. S2 and Fig. 6D) supports the idea that these mutants accumulate DNA 
damage when challenged with HU, as does their accumulation of H2A(X) phosphorylation 
(45).  HU-treated mrc1! cells display an increase of chromatin-bound cohesin complex 
similar to that of ctf18! (Fig. 6E), consistent with its resulting from the DNA replication 
checkpoint defect. 
 
The checkpoint kinase Mec1-Ddc2, homologue of human ATR-ATRIP, is recruited to RPA-
coated single-stranded DNA in response to HU or DNA damage (28).  We therefore suspect 
that increased chromatin loading of Mec1 is probably due to increased RPA loading in HU-
arrested ctf18! (Fig. 3), caused by single-stranded DNA accumulating at HU-blocked 
replication forks in this checkpoint-deficient mutant.  The reduction in chromatin-bound 
Plm2 we observed when either ctf18! or mrc1! is HU-treated probably also reflects the 
checkpoint defect.  Plm2 is a putative transcription factor that is phosphorylated in a Rad53-
dependent way (51, 52), and so altered Plm2 behavior is consistent with defective Rad53 
activation in HU-treated ctf18! and mrc1! cells.  In general, most of the chromatin 
abnormalities we observe in the HU-blocked ctf18! mutant can be interpreted as resulting 
from failure to activate the DNA replication checkpoint. 
 
What is the molecular activity of the Ctf18-RLC? 
In vitro, the Ctf18-RLC can load PCNA onto DNA and also unload it from DNA (9-11). 
Increased PCNA on chromatin in HU-treated ctf18! cells (Fig. 3) might be taken to suggest 
that Ctf18-RLC unloads PCNA from DNA in vivo.  However, since chromatin-associated 
PCNA also increased in HU-treated mrc1! cells (Fig. 6), it is likely that the increase in 
chromatin-bound PCNA in HU-treated ctf18! cells results mainly from loading of PCNA at 
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late origins, possibly mediated by RFC.  In contrast to our SILAC results, ChIP-microarray 
and ChIP-qPCR studies reported decreased PCNA in HU-treated ctf18! cells (16).  This 
apparent inconsistency may reflect different quantification methods.  In ChIP-microarray and 
ChIP-qPCR datasets it is difficult to distinguish between PCNA destabilization at replication 
forks, and replisomes that are themselves abnormally spread out (perhaps as a result of 
defective checkpoint activation).  
 
During normal S phase in ctf18! cells, we did observe a decrease in PCNA loading on 
chromatin (Fig. 4).  This result suggests that Ctf18 may load PCNA during normal S phase, 
possibly at specific genomic sites.  Further experiments will however be needed to test this 
idea, since reduced PCNA loading could equally be an indirect effect of the ctf18! mutation. 
 
It is unclear how the Ctf18-RLC mediates DNA replication checkpoint activation.  Since it 
binds DNA polymerase ! (53, 54), one possibility is that Ctf18-RLC coordinates the 
replisome components to allow checkpoint activation by RPA and Mec1.  Alternatively, the 
Ctf18-RLC might load or unload a modified form of PCNA required for checkpoint 
activation. 
 
Distinct functions of Ctf18-RLC and Elg1-RLC 
In contrast to the ctf18! mutant, yeast cells lacking Elg1 showed no increase in GINS, Cdc45 
and Ctf4 on chromatin, and displayed normal Rad53 activation on HU treatment (Fig. 7).  
Ctf18-RLC and Elg1-RLC therefore appear to have distinct roles in maintaining genome 
stability. 
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Association of PCNA with chromatin was increased in elg1! cells both during normal S 
phase and when replication forks are challenged by HU addition (Fig. 7).  This increased 
chromatin association of PCNA is unlikely to result from inappropriate late origin initiation, 
because there was no matching increase in Cdc45-MCM-GINS complex formation.  The 
accumulation of PCNA in elg1! could potentially result from failure of PCNA unloading by 
Elg1-RLC (although so far there has been no in vitro demonstration of PCNA unloading by 
Elg1-RLC).  Increased loading of the flap endonuclease Rad27 in elg1! cells may suggest 
involvement of Elg1 in PCNA transactions during Okazaki fragment maturation, a possibility 
requiring further investigation. 
 
Limitations of SILAC-based chromatin profiling 
Using SILAC analysis of HU-treated ctf18! chromatin we observed changes consistent with 
increased Cdc45-MCM-GINS-Ctf4 complex formation; however, the amount of Pol #-
primase in the chromatin fraction appeared slightly decreased (Fig. 3).  Further investigation 
of the behavior of Pol #-primase using co-IP experiments, including adjustment of assay 
conditions, suggested that interaction between the helicase complex and the Pol # subunit is 
actually increased in HU-treated ctf18! cells (Fig. 5C), in a way that resembles the increased 
association of other RPC components with helicase.  Increased Pol #-primase loading was 
not detected in our chromatin fractionation partly due to salt sensitivity of its interaction with 
the replisome (Fig. 5D), and partly because background levels of Pol #-primase binding to 
chromatin reduce the proportional increase observed on genuine replisome formation.  
Similarly, only small increases were observed in the chromatin association of certain other 
RPC subunits (e.g. Tof1, Spt16, Pob3 and Top1) in HU-treated ctf18! cells (Supplemental 
Fig. S4), probably because the proportion of these proteins bound non-specifically to 
chromatin obscures genuine increases in their replisome association (i.e. where background 
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association of a protein with chromatin is high, biologically meaningful changes can appear 
marginal).  These cases highlight the importance of considering the limitations of the 
chromatin enrichment procedure, and the implications for interpreting results.  
 
Conclusion and prospects 
Chromatin profiling using SILAC-based proteomics represents the first method to obtain a 
large-scale view of changes in chromatin composition.  This method is particularly useful in 
highlighting the significance of relatively small changes that nonetheless occur consistently 
amongst specific groups of proteins, and in this way has revealed that Ctf18 acts in the DNA 
replication checkpoint.  Our chromatin profiling approach will be very useful to investigate 
change in chromatin composition that occur in other mutant cells and in response to drugs.   
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FIGURE LEGENDS 
 
Figure 1. Outline of procedure for SILAC-based quantitative proteomic analysis of 
chromatin.  (A) ctf18! cells were metabolically labeled by culturing in 'heavy' media 
containing 
13
C/
15
N-isotopes of arginine and lysine, while wild-type cells were grown in 'light' 
media containing the 
12
C/
14
N-arginine and lysine isotopes.  After 10 generations, both 
cultures were synchronized by blocking in G1 phase with #-factor then releasing into HU-
containing heavy or light medium.  After 90 min, chromatin-enriched fractions were prepared 
(see Figure 2) and mixed.  Proteins were separated by 1D SDS-PAGE, digested, and 
subjected to LC-MS/MS analysis, allowing calculation of heavy:light ratios for the peptides 
and proteins identified.  Strains used are TKY1 and SHY201.  (B) Specimen MS spectrum 
for a PCNA peptide, showing increased loading of PCNA on chromatin in the ctf18! strain. 
 
Figure 2. Chromatin enrichment procedure and summary of proteins quantitated.  (A) 
Outline of chromatin enrichment procedure.  The nuclear isolation step incorporated into the 
published chromatin enrichment method is shown within the dashed box.  (B) Whole cell 
extract (WCE) and chromatin-enriched fraction (Ch) were analyzed by SDS-PAGE followed 
by SYPRO ruby staining.  100$ cell equivalents were loaded for Ch.  (C) Distribution of 
proteins in cytoplasmic (Cyto), nucleoplasm (NP), and chromatin (Ch) fractions during the 
enrichment procedure, analyzed by Western blotting.  10$ cell equivalents loaded for NP and 
Ch fractions.  (D) Pie chart summarizing S. cerevisiae protein categories and the distribution 
of proteins quantitated by SILAC.  The circle represents all 6,607 S. cerevisiae ORFs, with 
pie slices representing the number of ORFs with gene products in each category.  Within 
each pie slice, the shaded region represents those gene products quantitated in the SILAC 
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experiment.  Protein annotations generally according to the Saccharomyces Genome 
Database (see Experimental Procedures). 
 
Figure 3. Increased chromatin binding of DNA replication proteins, the checkpoint 
kinase Mec1, and cohesin proteins in HU-treated ctf18!  cells.  (A) Plot shows log2 ratios 
of all chromosome proteins identified and their summed peptide intensities.  In this and 
subsequent plots, the marker symbols indicate significance scores for the changes observed, 
with green diamonds indicating the highly significant abnormalities and blue crosses changes 
less likely to be significant.  ctf18! cells were labeled with [
13
C6]-Lys.  Strains used are 
SHY201 and TKY1.  (B) Schematic representation of replisome proteins, colored according 
to their altered chromatin loading.  (C) Western blot analysis confirms changed chromatin 
binding levels.  Western blots show whole cell extract (WCE; lanes 1 & 2) and chromatin-
enriched (Ch; lanes 3 & 4) fractions from strains with epitope-tagged proteins Rfa1-3HA, 
Ctf4-13Myc, PCNA-3Myc, or Psf2-13Myc.  Loading of Ch fractions was adjusted to be 
appropriate for each protein analyzed.  A dilution series of WT chromatin (lanes 5-8) allows 
the assembly of a standard plot for quantification.  Strains used are TKY27, TKY33, TKY25, 
TKY31, Y1109, SHY164, TKY22 and TKY23.  Top panel (Mcm2) shows TKY27 and 
TKY33.  (D) Histogram shows ctf18!/WT ratios in Ch fraction for each protein, as measured 
by Western blots. Ratios were calculated based on signal intensities normalized against levels 
of histone H3 (see also Supplemental Fig. S3).  (E) Histogram shows ctf18!/WT ratios in Ch 
fraction on log scale, as measured in SILAC analysis (open bars) and by Western blotting 
(filled bars). For Western blot analysis ratios, mean value and standard deviation (error bar) 
of Mcm2 from four experiments is shown.  For the SILAC analysis ratios, mean values and 
standard deviations (error bars) are derived from two independent experiments. 
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Figure 4. Chromatin binding levels of DNA replication proteins did not increase in 
ctf18!  cells during normal S phase.  (A) Cell cycle progression on release from #-factor 
analyzed by flow cytometry.  Wild-type and ctf18! cells were harvested when cells were in 
mid-S phase (27 min and 30 min respectively after release at 30
o
C).  Positions of cells with 
1C and 2C DNA contents are indicated.  Strains used are SHY201 and TKY1.  (B) Plot 
shows log2 ratios of all chromosome proteins identified and their summed peptide intensities.  
ctf18! cells were labeled with [
13
C6]-Arg and [
13
C6,
15
N2]-Lys.  (C) Western blot analysis 
confirms that levels of chromatin-bound PCNA are slightly decreased in ctf18! cells 
undergoing normal S phase.  Strains used are SHY201, TKY1, Y1109 and SHY164.  (D) 
Histogram shows ctf18!/WT ratios in Ch fraction for Mcm2 and PCNA, as measured in 
SILAC analysis and by Western blots.  For the SILAC analysis ratios, mean values and 
standard deviations (error bars) are derived from two independent experiments.  Levels of 
Mcm2 in contrast changed only marginally, as measured by SILAC or Western blotting.  
 
Figure 5. Increased association of GINS, Ctf4 and Cdc45 with MCM in HU-treated 
ctf18! , when compared to HU-treated wild-type cells.  Cells were synchronized in G1 
phase (G1) using #-factor, and then released in the presence of 200 mM HU for 90 min 
(HU).  Mcm4-3Flag was immunoprecipitated (Mcm4 IP), followed by analysis of co-
precipitated Psf2-13Myc (A), Ctf4-13Myc (B), or Cdc45 and Pol1-6HA (C: upper panels).  
Immunoblotting detection used anti-Flag, anti-Myc, anti-Cdc45 or anti-HA antibodies.  
Immunoprecipitation was also performed under low salt conditions (50 mM potassium 
acetate) (C: lower panels).  Strains used are TKY52, TKY78, TKY59 and TKY85.  (D) 
Histogram shows ctf18!/WT ratios of Mcm4 binding for Psf2-13Myc, Ctf4-13Myc, Cdc45 
and Pol1-6HA.  Values were normalized based on the amount of Mcm4-3Flag precipitated in 
each experiment. 
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Figure 6. Ctf18 acts in the DNA replication checkpoint response to HU.  (A) Two-
dimensional gel analysis of EcoRI fragments containing ARS305 (early origin) and ARS1413 
(late origin) in WT, ctf18! and mrc1! cells released into S phase in the presence of 200 mM 
HU for 90 min at 30°C.  Strains used are SHY201, TKY1 and TKY111.  (B) ctf18! cells are 
defective in activating Rad53 in response to HU.  Cells were arrested in G1 phase then 
released into S phase in the presence (upper panels) or absence (lower panels) of 200 mM 
HU at 25°C.  Cells were collected at the indicated time points and protein extracts prepared, 
followed by Western blotting to detect Rad53.  Arrowhead indicates unmodified Rad53 and 
the bracket, phosphorylated forms of Rad53.  Strains used are SHY201, TKY1, and TKY111. 
(C) An experiment similar to that in B shows that Rad53 activation in ctf18! depends on the 
DNA damage (Rad9-mediated) checkpoint. Strains are TKY130 and TKY131. (D) 
Chromatin abnormalities in cells lacking the checkpoint mediator Mrc1 treated with HU.  
Plot shows log2 ratios of all chromosome proteins identified and their summed peptide 
intensities.  mrc1! cells were labeled with [
13
C6]-Arg and [
13
C6,
15
N2]-Lys.  Strains used are 
SHY201 and TKY111.  (E) Abnormalities in chromatin composition in HU-treated ctf18! 
cells resemble those of HU-treated mrc1! cells.  Log2 ratios of chromatin association for 
mrc1!/WT in HU, plotted against log2 ratios of chromatin association for ctf18!/WT in HU.  
 
Figure 7. Chromatin association of PCNA and the flap endonuclease Rad27, but not 
Cdc45, GINS, or Ctf4, was increased in cells lacking Elg1.  (A) Changes in chromatin 
composition in HU-treated elg1! cells, compared to HU-treated wild-type.  elg1! cells were 
labeled with [
13
C6]-Arg and [
13
C6,
15
N2]-Lys.  Strains used are SHY201 and TKY18.  (B) 
Increase in chromatin-bound PCNA in HU-treated elg1! cells confirmed by Western blot 
analysis.  Strains used are SHY201 and TKY18.  (C) Changes in chromatin composition in 
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elg1! cells during normal S phase.  elg1! cells were labeled with [
13
C6]-Arg and [
13
C6,
15
N2]-
Lys.  Strains used are SHY201 and TKY18.  (D) Cell cycle progression was analyzed by 
flow cytometry.  Wild-type and elg1! cells were synchronized by blocking with #-factor in 
G1 phase and release into medium without HU.  Both cultures were harvested in mid-S 
phase, 27 min after release.  Positions of cells with 1C and 2C DNA contents are indicated.  
(E) Two-dimensional gel analysis of EcoRI fragments containing ARS305 and ARS1413 in 
elg1! cells released into S phase in the presence of 200 mM HU for 90 min at 30°C.  Strain 
used is TKY18.  (F) Kinetics of Rad53 phosphorylation in elg1! cells.  Rad53 was detected 
as in Figure 6B. 
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